Poly Medicure is surely a great opportunity, but I would like to have clarity on their US venture in terms of sales, working capitals and net effect on free cash flows before investing. I did this mistake earlier with Opto Circuits and won’t make the same mistake again.
Kajaria as I mentioned is in a sweet spot and the stock price seems to be in a long term bull run with minimal price corrections. However, most of the expectations are already priced in. Agree that FII money can take it to any levels, even doubling within a month, but risk is timing an exit in such cases. I would prefer a gradual rise in other stocks, looks like **Mayur **has mad e a mark again today
Agree with you on Granules but as mentioned I am riding Dishman and I feel it will make up for the opportunity lost in Granules. You can’t be at all places at once. Unlike the opportunity is super-normal (like in CPVC pipes) I generally won’t prefer multiple companies in the same business (unlike Astral, Supreme there). Good that you are riding both
Main problem with La Opala is the limited size of opportunity, Opalware and Bone China are two different markets. La Opala is the only branded player in Opal ware. The size of opportunity is limited. It can never be a Hawkins. Pressure Cooker is a must have utility while I don’t see a rural household buying La Opala dinner sets. Moreover I am always skeptical about Kolkata based companies (after Shree Ganesh Jewellery House). Just look at the delivery %ages and I see a froth building already.
Regarding Atul Auto, my doubts have been satisfactorily answered by esteemed ValuePickrs and Ayush in particular. (A big thanks to you Ayush :)) and I do foresee enough growth for next 4-5 years to ride this even at this point. Looking at the EV and the size of the opportunity is more relevant than the price.
Hope I have answered your queries.